Dimensional Fund Advisors LP Alkermes Plc. Transaction History

Dimensional Fund Advisors LP

$418 Billion
Q2 2025

A detailed history of Dimensional Fund Advisors LP transactions in Alkermes Plc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 3,096,637 shares of ALKS stock, worth $95.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,096,637

Previous 2,991,005 3.53%

Holding current value

$95.8 Million

Previous $98.8 Million 10.3%

% of portfolio

0.02%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$26.59 - $32.65 $2.81 Million - $3.45 Million	105,632 Added 3.53%	3,096,637 $88.6 Million
Q1 2025 May 13, 2025	SELL	$28.08 - $36.0 $800,364 - $1.03 Million	-28,503 Reduced 0.94%	2,991,005 $98.8 Million
Q4 2024 Feb 13, 2025	BUY	$25.7 - $31.46 $3.31 Million - $4.05 Million	128,701 Added 4.45%	3,019,508 $86.8 Million
Q3 2024 Nov 07, 2024	BUY	$23.01 - $28.55 $156,352 - $193,997	6,795 Added 0.24%	2,890,807 $80.9 Million
Q2 2024 Aug 09, 2024	BUY	$23.21 - $27.24 $8.61 Million - $10.1 Million	371,039 Added 14.76%	2,884,012 $69.5 Million
Q1 2024 May 10, 2024	BUY	$26.4 - $32.56 $2.9 Million - $3.57 Million	109,778 Added 4.57%	2,512,973 $68 Million
Q4 2023 Feb 07, 2024	BUY	$23.37 - $28.68 $2.11 Million - $2.59 Million	90,219 Added 3.9%	2,403,195 $66.7 Million
Q3 2023 Nov 09, 2023	BUY	$27.17 - $31.97 $3.1 Million - $3.65 Million	114,189 Added 5.19%	2,312,976 $64.8 Million
Q2 2023 Aug 09, 2023	BUY	$28.34 - $33.63 $931,394 - $1.11 Million	32,865 Added 1.52%	2,198,787 $68.8 Million
Q1 2023 May 12, 2023	BUY	$25.31 - $29.02 $448,290 - $514,002	17,712 Added 0.82%	2,165,922 $61.1 Million
Q4 2022 Feb 09, 2023	BUY	$21.94 - $26.24 $1.71 Million - $2.05 Million	78,132 Added 3.77%	2,148,210 $56.1 Million
Q3 2022 Nov 10, 2022	SELL	$22.0 - $31.87 $971,366 - $1.41 Million	-44,153 Reduced 2.09%	2,070,078 $46.2 Million
Q2 2022 Aug 12, 2022	SELL	$26.4 - $30.54 $615,991 - $712,589	-23,333 Reduced 1.09%	2,114,231 $63 Million
Q1 2022 May 13, 2022	SELL	$23.07 - $27.99 $1.09 Million - $1.32 Million	-47,232 Reduced 2.16%	2,137,564 $56.2 Million
Q4 2021 Feb 09, 2022	BUY	$21.47 - $32.08 $2.41 Million - $3.6 Million	112,077 Added 5.41%	2,184,796 $50.8 Million
Q3 2021 Nov 12, 2021	BUY	$23.37 - $32.13 $6.79 Million - $9.34 Million	290,637 Added 16.31%	2,072,719 $63.9 Million
Q2 2021 Aug 12, 2021	BUY	$18.78 - $25.15 $9.12 Million - $12.2 Million	485,629 Added 37.46%	1,782,082 $43.7 Million
Q1 2021 May 14, 2021	BUY	$18.21 - $23.2 $7.11 Million - $9.06 Million	390,553 Added 43.11%	1,296,453 $24.2 Million
Q4 2020 Feb 25, 2021	BUY	$15.39 - $22.1 $13.9 Million - $20 Million	905,900 New	905,900 $18.1 Million

Others Institutions Holding ALKS

# of Institutions

394

Shares Held

176M

Call Options Held

558K

Put Options Held

427K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.08B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Alkermes Plc. Transaction History